Deutsche Bank’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-30,306
| Closed | -$67K | – | 4711 |
|
|
2021
Q1 | $67K | Sell |
30,306
-2,568
| -8% | -$5.68K | ﹤0.01% | 4069 |
|
|
2020
Q4 | $82K | Buy |
32,874
+9,663
| +42% | +$24.1K | ﹤0.01% | 3873 |
|
|
2020
Q3 | $57K | Buy |
23,211
+1,894
| +9% | +$4.65K | ﹤0.01% | 3764 |
|
|
2020
Q2 | $76K | Sell |
21,317
-8,683
| -29% | -$31K | ﹤0.01% | 3546 |
|
|
2020
Q1 | $70K | Buy |
30,000
+16,135
| +116% | +$37.6K | ﹤0.01% | 3340 |
|
|
2019
Q4 | $30K | Buy |
13,865
+6,039
| +77% | +$13.1K | ﹤0.01% | 4021 |
|
|
2019
Q3 | $14K | Sell |
7,826
-14,664
| -65% | -$26.2K | ﹤0.01% | 4229 |
|
|
2019
Q2 | $31K | Sell |
22,490
-16,828
| -43% | -$23.2K | ﹤0.01% | 4420 |
|
|
2019
Q1 | $76K | Sell |
39,318
-2,444
| -6% | -$4.72K | ﹤0.01% | 4245 |
|
|
2018
Q4 | $53K | Sell |
41,762
-31,370
| -43% | -$39.8K | ﹤0.01% | 4234 |
|
|
2018
Q3 | $180K | Buy |
73,132
+12,280
| +20% | +$30.2K | ﹤0.01% | 4162 |
|
|
2018
Q2 | $205K | Buy |
60,852
+19,044
| +46% | +$64.2K | ﹤0.01% | 4155 |
|
|
2018
Q1 | $176K | Sell |
41,808
-29,689
| -42% | -$125K | ﹤0.01% | 4120 |
|
|
2017
Q4 | $234K | Buy |
71,497
+43,673
| +157% | +$143K | ﹤0.01% | 3808 |
|
|
2017
Q3 | $105K | Sell |
27,824
-46,452
| -63% | -$175K | ﹤0.01% | 3955 |
|
|
2017
Q2 | $325K | Buy |
+74,276
| New | +$325K | ﹤0.01% | 3570 |
|
|
2016
Q3 | – | Sell |
-7,314
| Closed | -$24K | – | 4729 |
|
|
2016
Q2 | $24K | Buy |
7,314
+5,265
| +257% | +$17.3K | ﹤0.01% | 4381 |
|
|
2016
Q1 | $4K | Buy |
2,049
+1,957
| +2,127% | +$3.82K | ﹤0.01% | 4610 |
|
|
2015
Q4 | $0 | Buy |
+92
| New | – | ﹤0.01% | 4854 |
|
|
2014
Q2 | – | Sell |
-800
| Closed | -$4K | – | 5422 |
|
|
2014
Q1 | $4K | Sell |
800
-2,597
| -76% | -$13K | ﹤0.01% | 4970 |
|
|
2013
Q4 | $20K | Sell |
3,397
-46,025
| -93% | -$271K | ﹤0.01% | 4624 |
|
|
2013
Q3 | $326K | Buy |
49,422
+22,822
| +86% | +$151K | ﹤0.01% | 3797 |
|
|
2013
Q2 | $134K | Buy |
+26,600
| New | +$134K | ﹤0.01% | 4039 |
|